Atlas Trials

Efficiency Study of Low Dose of IL-2 to Prevent Relapse in Standard Risk Leukemia After Transplantation

Clinical trial NCT01517347 · TERMINATED

Trial details

NCT number
NCT01517347
Sponsor
Peking University People's Hospital
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Leukemia
Start date
2012-01-01
Primary completion
2015-08-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.